PT Hetzer Medical Indonesia Tbk (MEDS.JK)
IDR 50.0
(0.0%)
IDR 50.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.22 Billion IDR | -78.19% |
| 2022 | 4.32 Billion IDR | -78.9% |
| 2021 | 36.03 Billion IDR | -27.5% |
| 2020 | 49.45 Billion IDR | 7784.73% |
| 2019 | 626.62 Million IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.29 Billion IDR | -459.29% |
| 2024 Q1 | 385.26 Million IDR | -92.4% |
| 2023 Q4 | 5.14 Billion IDR | 184.31% |
| 2023 FY | - IDR | -78.19% |
| 2023 Q3 | 1.81 Billion IDR | 176.8% |
| 2023 Q2 | -2.35 Billion IDR | 20.14% |
| 2023 Q1 | -2.95 Billion IDR | -379.93% |
| 2022 Q1 | 3.57 Billion IDR | 133.4% |
| 2022 FY | - IDR | -78.9% |
| 2022 Q4 | 1.05 Billion IDR | 0.0% |
| 2022 Q2 | 2.88 Billion IDR | -19.27% |
| 2021 Q4 | 1.53 Billion IDR | 0.0% |
| 2021 Q1 | 16.48 Billion IDR | 0.0% |
| 2021 FY | - IDR | -27.5% |
| 2020 FY | - IDR | 7784.73% |
| 2019 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Mark Dynamics Indonesia Tbk | 234.35 Billion IDR | 99.476% |
| PT Jayamas Medica Industri Tbk | 371.38 Billion IDR | 99.669% |
| Maja Agung Latexindo Tbk. | 978.07 Million IDR | -25.537% |